Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
10x Genomics, Inc. (TXG)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 15.1% | 19.6% | 24.8% | 19.6% | 14.9% |
| Gross profit | 84.9% | 80.4% | 75.2% | 80.4% | 85.1% |
| Selling, general and administrative | 52.5% | 67.7% | 53.2% | 60.1% | 65.7% |
| Research and development | 43.2% | 41.3% | 33.8% | 32.5% | 45.2% |
| EBITDA | -6.3% | -24.3% | -9.6% | -30.4% | -19.8% |
| Depreciation | 4.3% | 4.7% | 2.9% | 2.7% | 6.1% |
| EBIT | -10.7% | -29.0% | -12.4% | -33.1% | -25.8% |
| Pre-tax income | -11.0% | -178.8% | -12.6% | -76.8% | -26.4% |
| Income taxes | 0.9% | 2.8% | 0.1% | 0.1% | 0.0% |
| Net income | -11.9% | -181.6% | -12.7% | -76.9% | -26.4% |
|